FdaApplication

BLA 125387

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRegeneron Pharmaceuticals, Inc.
application_typeBLA
approval_date2011-11-18

Products (2)

ProductActive ingredientStrengthDosage form
EYLEAAFLIBERCEPT2MG/0.05MLINJECTABLE;INJECTION
EYLEA—2MG/0.05MLInjection

2 products